International Urology and Nephrology

, Volume 42, Issue 2, pp 325–330 | Cite as

Evaluation of routine application of P504S, 34βE12 and p63 immunostaining on 250 prostate needle biopsy specimens

  • Kitty Pavlakis
  • Konstantinos Stravodimos
  • Theodoros Kapetanakis
  • Alkiviadis Gregorakis
  • Sofia Athanassiadou
  • Olympia Tzaida
  • Constantinos Constantinides
Urology - Original Paper

Abstract

Background

We aimed to determine whether a standard P504S, 34βE12 and p63 immunostaining of prostate core needle biopsy specimens can optimize diagnostic accuracy of conventional staining methods.

Materials and methods

The staining properties of all three antibodies were evaluated on 250 prostate biopsies formerly diagnosed as benign.

Results

Lack of basal cell staining in more than three glands for 34βE12 and p63 occurred in 41 (27.5%) and 9 (6%) respective cases from the General Hospital pool. Respective figures from the Uropathology department specimens were 18 (18%) for 34βE12 and 8 (8%) for p63. With the aid of P504S positivity, a case of prostate cancer as well as another of atypical small acinar proliferation was discovered.

Conclusion

Despite its potential for important aid in accurate diagnosis, standard application of immunohistochemistry in prostate biopsy is not justified and should be reserved for equivocal cases where conventional pathology fails to be conclusive.

Keywords

Immunostaining Prostate cancer P504S 34βE12 p63 

References

  1. 1.
    Iczkowski KA, MacLennan GT, Bostwick DG (1997) Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. Am J Surg Pathol 21:1489–1495CrossRefPubMedGoogle Scholar
  2. 2.
    Chan TY, Epstein JI (1999) Follow-up of atypical prostate needle biopsies suspicious for cancer. Urology 53:351–355CrossRefPubMedGoogle Scholar
  3. 3.
    Ng VW, Koh M, Tan SY, Tan PH (2007) Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study. Am J Clin Pathol 127:248–253CrossRefPubMedGoogle Scholar
  4. 4.
    Jiang Z, Li C, Fischer A, Dresser K, Woda BA (2005) Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol 123:231–236CrossRefPubMedGoogle Scholar
  5. 5.
    Gown AM, Vogel AM (1984) Monoclonal antibodies to human intermediate filament proteins: distribution of filament proteins in normal human tissues. Am J Pathol 114:321–390Google Scholar
  6. 6.
    Shah RB, Zhou M, LeBlanc M, Snyder M, Rubin MA (2002) Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 26:1161–1168CrossRefPubMedGoogle Scholar
  7. 7.
    Tacha DE, Miller RT (2004) Use of p63/P504S monoclonal antibody cocktail in immunohistochemical staining of prostate tissue. Appl Immunohistochem Mol Morphol 12:75–78PubMedGoogle Scholar
  8. 8.
    Sanderson SO, Sebo TJ, Murphy LM, Neumann R, Slezak J, Cheville JC (2004) An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays. Am J Clin Pathol 121:220–225CrossRefPubMedGoogle Scholar
  9. 9.
    Shah RB, Kunju LP, Shen R, LeBlanc M, Zhou M, Rubin MA (2004) Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations. Am J Clin Pathol 122:517–523CrossRefPubMedGoogle Scholar
  10. 10.
    Molinié V, Hervé JM, Lugagne PM, Lebret T, Botto H (2006) Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy. BJU Int 97:1109–1115CrossRefPubMedGoogle Scholar
  11. 11.
    Humphrey PA, Kaleem Z, Swanson PE et al (1998) Pseudohyperplastic prostatic adenocarcinoma. Am J Surg Pathol 22:1239–1246CrossRefPubMedGoogle Scholar
  12. 12.
    Varma M, Linden MD, Amin MB (1999) Effect of formalin fixation and epitope retrieval techniques on antibody 34βE12 immunostaining of prostatic tissue. Mod Pathol 12:472–478PubMedGoogle Scholar
  13. 13.
    Multhaupt HA, Fessler JN, Warhol MJ (2000) Loss of high molecular weight cytokeratine antigenicity in prostate tissue obtained by transurethral resections. Arch Pathol Lab Med 124:1764–1767PubMedGoogle Scholar
  14. 14.
    Skinnider BF, Oliva E, Young RH, Amin MB (2005) Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma. Am J Surg Pathol 29:1252–1254Google Scholar
  15. 15.
    Hameed O, Sublett J, Humphrey PA (2005) Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma; a comparison of the immunohistochemical staining of 430 foci of radical prostatectomy and needle biopsy tissue. Am J Surg Pathol 29:579–587CrossRefPubMedGoogle Scholar
  16. 16.
    Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR, Jiang Z (2002) Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 26:921–925CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V. 2009

Authors and Affiliations

  • Kitty Pavlakis
    • 1
  • Konstantinos Stravodimos
    • 2
  • Theodoros Kapetanakis
    • 2
    • 4
  • Alkiviadis Gregorakis
    • 3
  • Sofia Athanassiadou
    • 1
  • Olympia Tzaida
    • 1
  • Constantinos Constantinides
    • 2
  1. 1.Pathology Department, “ATTIKON” University HospitalUniversity of Athens Medical SchoolAthensGreece
  2. 2.1st Urology Department, “Laikon” General HospitalUniversity of Athens Medical SchoolAthensGreece
  3. 3.2nd Urology Department, “ATTIKON” General HospitalUniversity of Athens Medical SchoolAthensGreece
  4. 4.Resident in UrologyAthensGreece

Personalised recommendations